Relevance of vitamin D on NAFLD and liver fibrosis detected by vibration controlled transient elastography in US adults: a cross-sectional analysis of NHANES 2017–2018

References

• Cotter TG, Rinella M. Nonalcoholic fatty liver disease 2020: the state of the disease. Gastroenterology. 2020;158(7):1–7.
   Web of Science ®Google Scholar
• Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology. 2006;43(2 Suppl 1): S99–S112.
   PubMed Web of Science ®Google Scholar
• Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202–209.
   PubMed Web of Science ®Google Scholar
• Saadeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology. 2002;123(3):745–750.
   PubMed Web of Science ®Google Scholar
• Eddowes PJ, Sasso M, Allison M, et al. Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156(6):1717–1730.
   PubMed Web of Science ®Google Scholar
• Zhang X, Heredia NI, Balakrishnan M, et al. Prevalence and factors associated with NAFLD detected by vibration controlled transient elastography among US adults: results from NHANES 2017-2018. PLoS One. 2021;16(6):e0252164.
   PubMed Web of Science ®Google Scholar
• Goltzman D, Miao D, Panda DK, et al. Effects of calcium and of the vitamin D system on skeletal and calcium homeostasis: lessons from genetic models. J Steroid Biochem Mol Biol. 2004;89-90(1-5):485–489.
   PubMed Web of Science ®Google Scholar
• El-Sharkawy A, Malki A. Vitamin D signaling in inflammation and cancer: molecular mechanisms and therapeutic implications. Molecules (Basel, Switzerland). 2020;25(14):3219.
   PubMed Web of Science ®Google Scholar
• Komolmit P, Kimtrakool S, Suksawatamnuay S, et al. Vitamin D supplementation improves serum markers associated with hepatic fibrogenesis in chronic hepatitis C patients: a randomized, double-blind, placebo-controlled study. Sci Rep. 2017;7(1):8905.
   PubMedGoogle Scholar
• von Essen MR, Kongsbak M, Schjerling P, et al. Vitamin D controls T cell antigen receptor signaling and activation of human T cells. Nat Immunol. 2010;11(4):344–349.
   PubMed Web of Science ®Google Scholar
• de la Guía-Galipienso F, Martínez-Ferran M, Vallecillo N, et al. Vitamin D and cardiovascular health. Clin Nutr. 2021;40(5):2946–2957.
   PubMed Web of Science ®Google Scholar
• Barchetta I, De Bernardinis M, Capoccia D, et al. Hypovitaminosis D is independently associated with metabolic syndrome in obese patients. PLoS One. 2013;8(7):e68689.
   PubMed Web of Science ®Google Scholar
• Abouzid M, Główka AK, Karaźniewicz-Łada M. Trend research of vitamin D receptor: bibliometric analysis. Health Informatics J. 2021;27(4):14604582211043158.
   Web of Science ®Google Scholar
• Heo NJ, Park HE, Yoon JW, et al. The association between vitamin D and nonalcoholic fatty liver disease assessed by controlled attenuation parameter. JCM. 2021;10(12):2611.
   Google Scholar
• Lee HK, Shin SR, Han AL. Metabolic dysfunction associated fatty liver disease (MAFLD) and serum vitamin D concentration in South Korea. Asia Pac J Clin Nutr. 2022;31(2):201–207.
   PubMed Web of Science ®Google Scholar
• Wang N, Chen C, Zhao L, et al. Vitamin D and nonalcoholic fatty liver disease: bi-directional mendelian randomization analysis. EBioMedicine. 2018;28:187–193.
   PubMed Web of Science ®Google Scholar
• Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases. Hepatology. 2018;67(1):328–357.
   PubMed Web of Science ®Google Scholar
• Kim HS, Rotundo L, Kothari N, et al. Vitamin D is associated with severity and mortality of non-alcoholic fatty liver disease: a US population-based study. J Clin Transl Hepatol. 2017;5(3):185–192.
   PubMedGoogle Scholar
• Petroff D, Blank V, Newsome PN, et al. Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis. Lancet Gastroenterol Hepatol. 2021;6(3):185–198.
   PubMed Web of Science ®Google Scholar
• Siddiqui MS, Vuppalanchi R, Van Natta ML, et al. Vibration-Controlled transient elastography to assess fibrosis and steatosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2019;17(1):156–163 e2.
   PubMed Web of Science ®Google Scholar
• Tao MH, Fulda KG. Association of magnesium intake with liver fibrosis among adults in the United States. Nutrients. 2021;13(1):142.
   PubMed Web of Science ®Google Scholar
• Liu X, Shen H, Chen M, et al. Clinical relevance of vitamins and carotenoids with liver steatosis and fibrosis detected by transient elastography in adults. Front Nutr. 2021;8:760985.
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612.
   PubMed Web of Science ®Google Scholar
• Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. J Am Coll Cardiol. 2018;71(19):2199–2269.
   PubMed Web of Science ®Google Scholar
• Liu S, Liu Y, Wan B, et al. Association between vitamin D status and Non-Alcoholic fatty liver disease: a Population-Based study. J Nutr Sci Vitaminol (Tokyo). 2019;65(4):303–308.
   PubMed Web of Science ®Google Scholar
• Wan B, Gao Y, Zheng Y, et al. Association between serum 25-hydroxy vitamin D level and metabolic associated fatty liver disease (MAFLD)-a population-based study. Endocr J. 2021;68(6):631–637.
   PubMed Web of Science ®Google Scholar
• Ha Y, Hwang SG, Rim KS. The association between vitamin D insufficiency and nonalcoholic fatty liver disease: a Population-Based study. Nutrients. 2017;9(8):806.
   PubMed Web of Science ®Google Scholar
• Leitão J, Carvalhana S, Silva AP, et al. No evidence for lower levels of serum vitamin D in the presence of hepatic steatosis. A study on the portuguese general population. Int J Med Sci. 2018;15(14):1778–1786.
   PubMed Web of Science ®Google Scholar
• Yuan S, Larsson SC. Inverse association between serum 25-Hydroxyvitamin D and nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol.. 2023;21(2):398–405.e4.
   PubMed Web of Science ®Google Scholar
• Liu XJ, Wang BW, Zhang C, et al. Vitamin d deficiency attenuates high-fat diet-induced hyperinsulinemia and hepatic lipid accumulation in male mice. Endocrinology. 2015;156(6):2103–2113.
   PubMed Web of Science ®Google Scholar
• Yang BB, Chen YH, Zhang C, et al. Low vitamin D status is associated with advanced liver fibrosis in patients with nonalcoholic fatty liver disease. Endocrine. 2017;55(2):582–590.
   PubMed Web of Science ®Google Scholar
• Arai T, Atsukawa M, Tsubota A, et al. Association of vitamin D levels and vitamin D-related gene polymorphisms with liver fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease. Dig Liver Dis. 2019;51(7):1036–1042.
   PubMedGoogle Scholar
• Udomsinprasert W, Jittikoon J. Vitamin D and liver fibrosis: molecular mechanisms and clinical studies. Biomed Pharmacother. 2019;109:1351–1360.
   PubMed Web of Science ®Google Scholar
• Beilfuss A, Sowa JP, Sydor S, et al. Vitamin D counteracts fibrogenic TGF-β signalling in human hepatic stellate cells both receptor-dependently and independently. Gut. 2015;64(5):791–799.
   PubMed Web of Science ®Google Scholar
• Lu W, Li X, Liu N, et al. Vitamin D alleviates liver fibrosis by inhibiting histidine-rich calcium binding protein (HRC). Chem Biol Interact. 2021;334:109355.
   PubMed Web of Science ®Google Scholar
• Lukenda Zanko V, Domislovic V, Trkulja V, et al. Vitamin D for treatment of non-alcoholic fatty liver disease detected by transient elastography: a randomized, double-blind, placebo-controlled trial. Diabetes Obes Metab. 2020;22(11):2097–2106.
   PubMed Web of Science ®Google Scholar
• Barchetta I, Del Ben M, Angelico F, et al. No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial. BMC Med. 2016;14:92.
   PubMed Web of Science ®Google Scholar